findmyKOL

Albert Khouri, MD

Enriched profile

Professor of Ophthalmology, Director of the Glaucoma Division, and Program Director of the Ophthalmology Residency · Rutgers New Jersey Medical School

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Newark, NJ · Northeast · United StatesSpecialtyOphthalmologyFocusGlaucoma
Active KOLfindmyKOL type: EliteLatest publication2024Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Albert Khouri is Professor of Ophthalmology, Director of the Glaucoma Division, and Program Director of the Ophthalmology Residency at Rutgers New Jersey Medical School. OpenAlex indexes 285 publications with 1,801 citations (h-index 21); ClinicalTrials.gov lists 1 registered study with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 14 Oct 2026

Albert S. Khouri, MD, is Professor of Ophthalmology, Director of the Glaucoma Division, and Program Director of the Ophthalmology Residency at Rutgers New Jersey Medical School, Department of Ophthalmology & Visual Science. The public record shows 285 publications with 1,801 citations (h-index 21), centered on Glaucoma. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 15 companies.

  • Most recent indexed publication: 2024 · Journal of current glaucoma practice
  • Top research focus: Glaucoma
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 15 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Glaucoma1 trialComa1 trial

Research focus

OpenAlex concept fingerprint
Glaucoma

Drugs & molecules

across trials, industry payments and publications
Durystageneric · BimatoprostClinical trials—Industry payments99Publications—Vyzultageneric · Latanoprostene bunodClinical trials—Industry payments90Publications—Rocklatangeneric · Latanoprost / netarsudilClinical trials—Industry payments32Publications—Rhopressageneric · NetarsudilClinical trials—Industry payments22Publications—Combigangeneric · Brimonidine / timololClinical trials—Industry payments11Publications—Simbrinzageneric · Brimonidine / brinzolamideClinical trials—Industry payments7Publications—Vuitygeneric · PilocarpineClinical trials—Industry payments7Publications—Miebogeneric · PerfluorohexyloctaneClinical trials—Industry payments4Publications—BrimonidineClinical trials—Industry payments3Publications—CyclosporineClinical trials—Industry payments3Publications—Ozurdexgeneric · DexamethasoneClinical trials—Industry payments2Publications—Travoprost Intraocular Implant - iDoseClinical trials—Industry payments2Publications—

Works with

trial sponsors and companies reporting payments
Bausch & Lomb Americas Inc.Clinical trials—Industry payments90Abbvie Inc.Clinical trials—Industry payments57Allergan, Inc.Clinical trials—Industry payments56Alcon Vision LLCClinical trials—Industry payments29Glaukos CorporationClinical trials—Industry payments28Sight Sciences, Inc.Clinical trials—Industry payments7Aerie Pharmaceuticals, Inc.Clinical trials—Industry payments6Bausch & Lomb, a division of Bausch Health US, LLCClinical trials—Industry payments6New World Medical,Inc.Clinical trials—Industry payments4Biotissue Holdings Inc.Clinical trials—Industry payments1Dompe US, Inc.Clinical trials—Industry payments1Horizon Therapeutics plcClinical trials—Industry payments1Iridex CorporationClinical trials—Industry payments1Rutgers UniversityClinical trials1Industry payments—Tarsus Pharmaceuticals, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
285publications

Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.

1,801citations

Total citations across indexed works.

21h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
15companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

15 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    88.7%
    Prostaglandin Analog28.8%
    Latanoprost59%Lumigan31%Travoprost6%Bimatoprost1%Zioptan1%Tafluprost1%Travatan Z1%
    Part D<11 patients
    Carbonic Anhydrase Inhibitor28.4%
    Dorzolamide-Timolol56%Dorzolamide Hcl19%Simbrinza14%Acetazolamide4%Brinzolamide4%Acetazolamide Er1%Azopt1%
    Part D<11 patients

    + 6 more classes in this area

  • Cardiovascular

    6.9%
    Beta blocker6.9%
    Timolol Maleate100%
    Part D≥112 patients
  • Cancer & immunology

    1.6%
    Calcineurin inhibitor1.6%
    Restasis77%Cyclosporine24%
    Part D<11 patients
All 8 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/albert-khouri-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/albert-khouri-a0a4a58b

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗

Mentions by others

where others cite or feature them
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • LinkedIn

    LinkedIn: "Albert Khouri - Professor of Ophthalmology, Glaucoma Director, Residency Director at Rutgers New Jersey Medical School"

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • Health.usnews.com

    Search-snippet-reported affiliation with Veterans Affairs New Jersey Health Care System-East Orange (unconfirmed on a primary Rutgers/VA page)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    American University of Beirut, Lebanon

    1992
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
  • BS

    American University of Beirut, School of Arts & Sciences, Lebanon

    1988
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
  • Board Certified

    Ophthalmology (American Board of Ophthalmology)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗

Editorial & leadership roles

journal and society appointments
  • Program Director

    Ophthalmology Residency, Rutgers New Jersey Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
  • Director

    Glaucoma Division, Rutgers New Jersey Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
  • Medical Director

    Ophthalmology Telemedicine, Rutgers New Jersey Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗
  • Mentor

    NJMS Sight Savers Program (student clinical-research mentorship)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →glaucomatoday.com ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • University Hospital

    Newark, NJ (hospital affiliation)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →njms-web.njms.rutgers.edu ↗

Media & interviews

press, podcasts and appearances
  • Guest

    "Telemedicine in Glaucoma" episode (S2E9), Eye Tea Ophthalmology Podcast, with Drs. Ben Szirth and Natasha Kolomeyer

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →eyetea.club ↗

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.